top of page

Home
About
All News
Contact
Advertise
Members
More

Use tab to navigate through the menu items.

News & Latest Updates

All Posts
Guidelines
Clinical Trials
Patient Stories & PEL
Case Reports
New Approvals
Spotlight

Semaglutide – the first type 2 diabetes oral pill in its class

Semaglutide – the first type 2 diabetes oral pill in its class

Semaglutide – the first type 2 diabetes oral pill in its class

Diabetes is a global epidemic affecting around 463 million adults worldwide (1). India is considered the diabetes capital of the world....

Dr. Lokesh Naik

Sep 104 min read

Oral Semaglutide vs Empagliflozin: PIONEER 2 Study

Oral Semaglutide vs Empagliflozin: PIONEER 2 Study

Oral Semaglutide vs Empagliflozin: PIONEER 2 Study

Rodbard HW et al conducted the PIONEER 2 clinical study to assess the efficacy of oral Semaglutide in comparison with Empagliflozin in...

Sep 91 min read

Oral Semaglutide vs. Sitagliptin: PIONEER 3 Study

Oral Semaglutide vs. Sitagliptin: PIONEER 3 Study

Oral Semaglutide vs. Sitagliptin: PIONEER 3 Study

Rosenstock J et al. conducted the PIONEER 3 trial to compare the effectiveness of oral Semaglutide against Sitagliptin in adult Type 2...

Ms. Silpa Rani Gajavalli

Sep 92 min read

Cardiovascular outcomes with Semaglutide in high-risk patients

Cardiovascular outcomes with Semaglutide in high-risk patients

Cardiovascular outcomes with Semaglutide in high-risk patients

Oral Semaglutide was approved by the FDA in September 2019 to improve blood glucose control in adult patients with type 2 diabetes (1). ...

Ms. Roma Joglekar

Sep 92 min read

Subscribe to Our Newsletter

Join our mailing list

Email*

I want to subscribe to your mailing list.

Home
About
All News
Contact
Advertise
Members

© 2025 RxNews. All Right Reserved.

bottom of page